Literature DB >> 19222228

Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.

Joseph E Deweese1, Amber M Burch, Alex B Burgin, Neil Osheroff.   

Abstract

All type II topoisomerases require divalent metal ions to cleave and ligate DNA. To further elucidate the mechanistic basis for these critical enzyme-mediated events, the role of the metal ion in the DNA cleavage reaction of human topoisomerase IIbeta was characterized and compared to that of topoisomerase IIalpha. This study utilized divalent metal ions with varying thiophilicities in conjunction with DNA cleavage substrates that substituted a sulfur atom for the 3'-bridging oxygen or the nonbridging oxygens of the scissile phosphate. On the basis of time courses of DNA cleavage, cation titrations, and metal ion mixing experiments, we propose the following model for the use of divalent metal ions by human type II topoisomerases. First, both enzymes employ a two-metal ion mechanism to support DNA cleavage. Second, an interaction between one divalent metal ion and the 3'-bridging atom of the scissile phosphate greatly enhances enzyme-mediated DNA cleavage, most likely by stabilizing the leaving 3'-oxygen. Third, there is an important interaction between a divalent second metal ion and a nonbridging atom of the scissile phosphate that stimulates DNA cleavage mediated by topoisomerase IIbeta. If this interaction exists in topoisomerase IIalpha, its effects on DNA cleavage are equivocal. This last aspect of the model highlights a difference in metal ion utilization during DNA cleavage mediated by human topoisomerase IIalpha and IIbeta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222228      PMCID: PMC2693261          DOI: 10.1021/bi8023256

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta.

Authors:  Yi Lisa Lyu; James C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

2.  The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase.

Authors:  S T Dobbs; P M Cullis; A Maxwell
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

Review 3.  Moving one DNA double helix through another by a type II DNA topoisomerase: the story of a simple molecular machine.

Authors:  J C Wang
Journal:  Q Rev Biophys       Date:  1998-05       Impact factor: 5.318

Review 4.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

5.  Thiophilic metal ion rescue of phosphorothioate interference within the Tetrahymena ribozyme P4-P6 domain.

Authors:  S Basu; S A Strobel
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

6.  Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).

Authors:  M Cornarotti; S Tinelli; E Willmore; F Zunino; L M Fisher; C A Austin; G Capranico
Journal:  Mol Pharmacol       Date:  1996-12       Impact factor: 4.436

7.  Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.

Authors:  P S Kingma; C A Greider; N Osheroff
Journal:  Biochemistry       Date:  1997-05-20       Impact factor: 3.162

8.  NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.

Authors:  Eriko Toyoda; Shigehide Kagaya; Ian G Cowell; Aya Kurosawa; Keiichi Kamoshita; Kiyohiro Nishikawa; Susumu Iiizumi; Hideki Koyama; Caroline A Austin; Noritaka Adachi
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

9.  A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine.

Authors:  S H Elsea; Y Hsiung; J L Nitiss; N Osheroff
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

10.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  10 in total

1.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

2.  Arginine as a general acid catalyst in serine recombinase-mediated DNA cleavage.

Authors:  Ross A Keenholtz; Kent W Mouw; Martin R Boocock; Nan-Sheng Li; Joseph A Piccirilli; Phoebe A Rice
Journal:  J Biol Chem       Date:  2013-08-22       Impact factor: 5.157

3.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

Review 4.  The use of divalent metal ions by type II topoisomerases.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Metallomics       Date:  2010-05-21       Impact factor: 4.526

5.  The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining.

Authors:  Gagandeep Narula; Thirunavukkarasu Annamalai; Sandra Aedo; Bokun Cheng; Elena Sorokin; Agnes Wong; Yuk-Ching Tse-Dinh
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

Review 6.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

7.  Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.

Authors:  Joseph E Deweese; F Peter Guengerich; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

8.  Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV.

Authors:  Steven L Pitts; Grace F Liou; Lesley A Mitchenall; Alex B Burgin; Anthony Maxwell; Keir C Neuman; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2011-02-07       Impact factor: 16.971

9.  The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.

Authors:  Kathryn L Gilroy; Caroline A Austin
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

10.  Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2013-03-04       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.